Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo

Cited by (1,067)

Items 901–1,000 of 1,067

1. Diabetes Mellitus Induces Alzheimer’s Disease Pathology: Histopathological Evidence from Animal Models
   Nobuyuki Kimura · 2016 · International Journal of Molecular Sciences
2. The Low Density Lipoprotein Receptor-related Protein 1 Mediates Uptake of Amyloid β Peptides in an in Vitro Model of the Blood-Brain Barrier Cells
   Kaoru Yamada, Tadafumi Hashimoto, Chiori Yabuki, Yusuke Nagae, Masanori Tachikawa, Dudley K. Strickland, Qiang Liu, Guojun Bu, Jacob M. Basak, David M. Holtzman et al. · 2008 · Journal of Biological Chemistry
3. Synapses and Dendritic Spines as Pathogenic Targets in Alzheimer’s Disease
   Wendou Yu, Bingwei Lu · 2012 · Neural Plasticity
4. Amyloid β oligomerization is induced by brain lipid rafts
   Sang‐Il Kim, Jae-Sung Yi, Young‐Gyu Ko · 2006 · Journal of Cellular Biochemistry
5. Novel therapeutic strategies for the treatment of protein-misfolding diseases
   Jean‐Christophe Rochet · 2007 · Expert Reviews in Molecular Medicine
6. Leptin prevents hippocampal synaptic disruption and neuronal cell death induced by amyloid β
   Gayle Helane Doherty, Dayne A. Beccano-Kelly, Shi Du Yan, Frank J. Gunn‐Moore, Jenni Harvey · 2012 · Neurobiology of Aging
7. High molecular mass assemblies of amyloid-β oligomers bind prion protein in patients with Alzheimer’s disease
   Frank Dohler, Diego Sepúlveda Falla, Susanne Krasemann, Hermann C. Altmeppen, Hartmut Schlüter, Diana Hildebrand, Inga Zerr, Jakob Matschke, Markus Glatzel · 2014 · Brain
8. Visual and fluorescent assays for selective detection of beta-amyloid oligomers based on the inner filter effect of gold nanoparticles on the fluorescence of CdTe quantum dots
   Ning Xia, Binbin Zhou, Nanbing Huang, Mengsha Jiang, Jiebing Zhang, Lin Liu · 2016 · Biosensors and Bioelectronics
9. The various aggregation states of β-amyloid 1–42 mediate different effects on oxidative stress, neurodegeneration, and BACE-1 expression
   Elena Tamagno, Paola Bardini, Michela Guglielmotto, Oliviero Danni, Massimo Tabaton · 2006 · Free Radical Biology and Medicine
10. Formation of Toxic Aβ(1–40) Fibrils on GM1 Ganglioside-Containing Membranes Mimicking Lipid Rafts: Polymorphisms in Aβ(1–40) Fibrils
    Takuma Okada, Keisuke Ikeda, Masaki Wakabayashi, Mariko Ogawa, Katsumi Matsuzaki · 2008 · Journal of Molecular Biology
11. β-Amyloid deposition in brain is enhanced in mouse models of arterial hypertension
    Maria Teresa Gentile, Roberta Poulet, Alba Di Pardo, Giuseppe Cifelli, Angelo Maffei, Carmine Vecchione, Francesca Passarelli, Alessandro Landolfi, Pierluigi Carullo, Giuseppe Lembo · 2007 · Neurobiology of Aging
12. Aβ Oligomer-Mediated Long-Term Potentiation Impairment Involves Protein Phosphatase 1-Dependent Mechanisms
    Marlen Knobloch, Mélissa Farinelli, Uwe Konietzko, Roger M. Nitsch, Isabelle M. Mansuy · 2007 · Journal of Neuroscience
13. Protein aggregation, metals and oxidative stress in neurodegenerative diseases
    B.J. Tabner, O.M.A. El-Agnaf, Matthew J. German, Nigel J. Fullwood, David Allsop · 2005 · Biochemical Society Transactions
14. Activation of the c-Jun N-terminal Kinase Signaling Cascade Mediates the Effect of Amyloid-β on Long Term Potentiation and Cell Death in Hippocampus
    Aedín M. Minogue, Adrien W. Schmid, Marie P. Fogarty, Alison C. Moore, Veronica A. Campbell, Caroline E. Herron, Marina A. Lynch · 2003 · Journal of Biological Chemistry
15. The keystone of Alzheimer pathogenesis might be sought in Aβ physiology
    Puzzo, D., Gulisano, W., Arancio, O., Palmeri, A. · 2015 · Neuroscience
16. Folding events in the 21-30 region of amyloid β-protein (Aβ) studied in silico
    Jose M. Borreguero, Brigita Urbanc, Noel D. Lazo, Sergey V. Buldyrev, David B. Teplow, Eugene Stanley · 2005 · Proceedings of the National Academy of Sciences
17. The amyloid-cell membrane system. The interplay between the biophysical features of oligomers/fibrils and cell membrane defines amyloid toxicity
    Cristina Cecchi, Massimo Stefani · 2013 · Biophysical Chemistry
18. Protofibril Formation of Amyloid β-Protein at Low pH via a Non-cooperative Elongation Mechanism
    Rita Carrotta, Mauro Manno, Donatella Bulone, Vincenzo Martorana, Pier Luigi San Biagio · 2005 · Journal of Biological Chemistry
19. The Structural Basis for Optimal Performance of Oligothiophene‐Based Fluorescent Amyloid Ligands: Conformational Flexibility is Essential for Spectral Assignment of a Diversity of Protein Aggregates
    Therése Klingstedt, Hamid Shirani, Andreas Åslund, Nigel J. Cairns, Christina J. Sigurdson, Michel Goedert, K. Peter R. Nilsson · 2013 · Chemistry - A European Journal
20. Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer’s disease
    Syed Faraz Kazim, Khalid Iqbal · 2016 · Molecular Neurodegeneration
21. Synaptic Elimination in Neurological Disorders
    Pablo Leal Cardozo, Izabella B. Q. de Lima, Esther M. A. Maciel, Nathália C. Silva, Tomáš Dobránsky, Fabiola Mara Ribeiro · 2019 · Current Neuropharmacology
22. MKP-1 reduces Aβ generation and alleviates cognitive impairments in Alzheimer’s disease models
    Yehong Du, Yexiang Du, Yun Zhang, Zhilin Huang, Min Fu, Junjie Li, Yayan Pang, Peng Lei, Yu Tian Wang, Weihong Song et al. · 2019 · Signal Transduction and Targeted Therapy
23. Amyloid-β oligomers in cellular models of Alzheimer’s disease
    Fontana, Igor C., Zimmer, Aline R., Rocha, Andreia S., Gosmann, Grace, Souza, Diogo O., Lourenco, Mychael V., Ferreira, Sergio T., Zimmer, Eduardo R. · 2020 · Journal of Neurochemistry
24. Membrane Protein Stoichiometry Determined from the Step‐Wise Photobleaching of Dye‐Labelled Subunits
    Somes Kumar Das, Manjula Darshi, Stephen Cheley, Mark Ian Wallace, Hagan Bayley · 2007 · ChemBioChem
25. Effects of turmeric on Alzheimer′s disease with behavioral and psychological symptoms of dementia
    Nozomi Hishikawa, Yoriko Takahashi, Yoshinobu Amakusa, Yuhei Tanno, Yoshitake Tuji, Hisayoshi Niwa, Nobuyuki Murakami, UK Krishna · 2012 · AYU (An International Quarterly Journal of Research in Ayurveda)
26. Nucleated polymerization with secondary pathways. III. Equilibrium behavior and oligomer populations
    Samuel I. A. Cohen, Michele Vendruscolo, Christopher Martin Dobson, Tuomas P. J. Knowles · 2011 · The Journal of Chemical Physics
27. Structure activity relationship of phenolic acid inhibitors of α-synuclein fibril formation and toxicity
    Mustafa Taleb Ardah, Katerina E. Paleologou, Guohua Lv, Salema B. Abul Khair, Abdulla S. Kazim, Saeed Tariq Minhas, Taleb H. Al‐Tel, Abdulmonem A. Al-Hayani, Mohammed Emdadul Haque, David Eliezer et al. · 2014 · Frontiers in Aging Neuroscience
28. Impaired regulation of synaptic actin cytoskeleton in Alzheimer's disease
    Peter Penzes, Jon‐Eric VanLeeuwen · 2011 · Brain Research Reviews
29. Soluble Arctic amyloid β protein inhibits hippocampal long‐term potentiation in vivo
    Igor V. Klyubin, Dominic M. Walsh, William K. Cullen, Julia V. Fadeeva, Roger Anwyl, Dennis J. Selkoe, Michael J. Rowan · 2004 · European Journal of Neuroscience
30. Formation of Toxic Fibrils of Alzheimer’s Amyloid β-Protein-(1–40) by Monosialoganglioside GM1, a Neuronal Membrane Component
    Takuma Okada, Masaki Wakabayashi, Keisuke Ikeda, Katsumi Matsuzaki · 2007 · Journal of Molecular Biology
31. Normal induction but accelerated decay of LTP in APP + PS1 transgenic mice
    Irina Gureviciene, Sami Ikonen, Kestutis Gurevicius, Alireza Sarkaki, Th. Van Groen, Raimo Pussinen, Aarne Ylinen, Heikki Tanila · 2004 · Neurobiology of Disease
32. Clinical and Neuropathological Features of the Arctic APP Gene Mutation Causing Early-Onset Alzheimer Disease
    Basun, Hans, Bogdanovic, Nenad, Ingelsson, Martin, Almkvist, Ove, Näslund, Jan, Axelman, Karin, Bird, Thomas D., Nochlin, David, Schellenberg, Gerard D., Wahlund, Lars-Olof et al. · 2008 · Archives of Neurology
33. Gelsolin amyloidosis: genetics, biochemistry, pathology and possible strategies for therapeutic intervention
    James P. Solomon, Lesley J. Page, William E. Balch, Jeffery W. Kelly · 2012 · Critical Reviews in Biochemistry and Molecular Biology
34. Amyloid-β induced signaling by cellular prion protein and Fyn kinase in Alzheimer disease
    Ji Won Um, Stephen M. Strittmatter · 2013 · Prion
35. Dysfunction of TGF-β1 signaling in Alzheimer’s disease: perspectives for neuroprotection
    Filippo Caraci, Simona Federica Spampinato, Maria Angela Sortino, Paolo Bosco, Giuseppe Battaglia, Valeria Bruno, Filippo Drago, Ferdinando Nicoletti, Agata Copani · 2011 · Cell and Tissue Research
36. Are N- and C-terminally truncated Aβ species key pathological triggers in Alzheimer's disease?
    Julie Dunys, Audrey Valverde, Frédéric Checler · 2018 · Journal of Biological Chemistry
37. Cerebrospinal fluid biomarkers for understanding multiple aspects of Alzheimer’s disease pathogenesis
    Kunal Dhiman, Kaj Blennow, Henrik Zetterberg, Ralph Nigel Martins, Veer Bala Gupta · 2019 · Cellular and Molecular Life Sciences
38. Differential neuroimmune markers to the onset of Alzheimer's disease neurodegeneration and dementia: Autoantibodies to Aβ(25–35) oligomers, S100b and neurotransmitters
    Грудень Марина Алексеевна, Tatyana B. Davidova, Mantas Mališauskas, Robert D. E. Sewell, Nina I. Voskresenskaya, K. Wilhelm, E. I. Elistratova, Vladimir V. Sherstnev, Ludmilla A. Morozova‐Roche · 2007 · Journal of Neuroimmunology
39. β-Amyloid Modulation of Synaptic Transmission and Plasticity
    Deepa V. Venkitaramani, Jeannie Chin, William J. Netzer, Gunnar K. Gouras, Sylvain Lesné, Roberto Malinow, Paul J. Lombroso · 2007 · Journal of Neuroscience
40. Mutations in amyloid precursor protein and presenilin‐1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid β‐peptide (1–42), H2O2 and kainic acid: implications for Alzheimer's disease
    Hafiz Mohmmad Abdul, Rukhsana Sultana A, Jeffrey N. Keller, Daret K. St. Clair, William R. Markesbery, David Allan Butterfield · 2006 · Journal of Neurochemistry
41. Generation and Therapeutic Efficacy of Highly Oligomer-Specific β-Amyloid Antibodies
    Hillen, Heinz, Barghorn, Stefan, Striebinger, Andreas, Labkovsky, Boris, Müller, Reinhold, Nimmrich, Volker, Nolte, Marc W., Perez-Cruz, Claudia, van der Auwera, Ingrid, van Leuven, Fred et al. · 2010 · The Journal of Neuroscience
42. Plaques, Tangles, and Memory Loss in Mouse Models of Neurodegeneration
    Eriksen, Jason L., Janus, Christopher G. · 2007 · Behavior Genetics
43. Overlapping profiles of Aβ peptides in the Alzheimer's disease and pathological aging brains
    Brenda D. Moore, Paramita Chakrabarty, Yona Levites, Tom L Kukar, Ann-Marie T. Baine, Tina Moroni, Thomas B. Ladd, Pritam Das, Dennis W. Dickson, Todd Eliot Golde · 2012 · Alzheimer s Research & Therapy
44. Amyloid β and APP as biomarkers for Alzheimer’s disease
    Henrik Zetterberg, Kaj Blennow, Eric Hanse · 2009 · Experimental Gerontology
45. Oligomeropathies and pathogenesis of Alzheimer and Parkinson's diseases
    Gianluigi Forloni, Vladimiro Artuso, Pietro La Vitola, Claudia Balducci · 2016 · Movement Disorders
46. Alzheimer's disease in the omics era
    Giulia Maria Sancesario, Sergio Bernardini · 2018 · Clinical Biochemistry
47. Amyloid-β Protofibrils Differ from Amyloid-β Aggregates Induced in Dilute Hexafluoroisopropanol in Stability and Morphology
    Michael R. Nichols, Melissa A. Moss, Dana Kim Reed, Stephanie Cratic-McDaniel, Jan H. Hoh, Terrone L. Rosenberry · 2004 · Journal of Biological Chemistry
48. Synthesis of quinoline derivatives: Discovery of a potent and selective phosphodiesterase 5 inhibitor for the treatment of Alzheimer's disease
    Jole Fiorito, Faisal Saeed, Hong Zhang, Agnieszka Staniszewski, Yan Feng, Yitshak I. Francis, Sudha R. Rao, Devarshi M. Thakkar, Shi‐Xian Deng, Donald W. Landry et al. · 2012 · European Journal of Medicinal Chemistry
49. MAPK recruitment by β‐amyloid in organotypic hippocampal slice cultures depends on physical state and exposure time
    Karen A. Bell, Kenneth J. O’Riordan, J. David Sweatt, Kelly T. Dineley · 2004 · Journal of Neurochemistry
50. Neurological disorders and therapeutics targeted to surmount the blood–brain barrier
    Jagat R. Kanwar, Sriramoju, Kanwar · 2012 · International Journal of Nanomedicine
51. Suppression of InsP3Receptor-Mediated Ca2+Signaling Alleviates Mutant Presenilin-Linked Familial Alzheimer's Disease Pathogenesis
    Dustin J. Shilling, Marioly Müller, Hajime Takano, Don‐On Daniel Mak, Ted G. Abel, Douglas A. Coulter, J. Kevin Foskett · 2014 · Journal of Neuroscience
52. Amyloid β -Protein Assembly as a Therapeutic Target of Alzheimers Disease
    Ghiam Yamin, Kenjiro Ono, Mohammed Inayathullah, David B. Teplow · 2008 · Current Pharmaceutical Design
53. Kinetics of Amyloid β-Protein Degradation Determined by Novel Fluorescence- and Fluorescence Polarization-based Assays
    Malcolm A. Leissring, Alice Lu, Margaret M. Condron, David B. Teplow, Ross L. Stein, Wesley Farris, Dennis J. Selkoe · 2003 · Journal of Biological Chemistry
54. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer’s disease
    Xunhu Gu, Li-Jun Xu, Zhiqiang Liu, Bo Wei, Yuan‐Jian Yang, Guogang Xu, Xiaoping Yin, Wei Wang · 2016 · Behavioural Brain Research
55. Amyloid-<i>β</i>-Induced Dysregulation of AMPA Receptor Trafficking
    Guntupalli, Sumasri, Widagdo, Jocelyn, Anggono, Victor · 2016 · Neural Plasticity
56. Dynamic Analysis of Amyloid β-Protein in Behaving Mice Reveals Opposing Changes in ISF versus Parenchymal Aβ during Age-Related Plaque Formation
    Hong, Soyon, Quintero-Monzon, Omar, Ostaszewski, Beth L., Podlisny, Daniel R., Cavanaugh, William T., Yang, Ting, Holtzman, David M., Cirrito, John R., Selkoe, Dennis J. · 2011 · The Journal of Neuroscience
57. Amyloid-β Peptides and Tau Protein as Biomarkers in Cerebrospinal and Interstitial Fluid Following Traumatic Brain Injury: A Review of Experimental and Clinical Studies
    Parmenion P. Tsitsopoulos, Niklas Marklund · 2013 · Frontiers in Neurology
58. Quantifying misfolded protein oligomers as drug targets and biomarkers in Alzheimer and Parkinson diseases
    Klara Kulenkampff, Adriana-M. Wolf Perez, Pietro Sormanni, Johnny Habchi, Michele Vendruscolo · 2021 · Nature Reviews Chemistry
59. Aβ-globulomers are formed independently of the fibril pathway
    Gerald P. Gellermann, Helga Byrnes, Andreas Striebinger, Kathrin Ullrich, Reinhold Mueller, Heinz Hillen, Stefan Barghorn · 2008 · Neurobiology of Disease
60. Influence of fluorinated and hydrogenated nanoparticles on the structure and fibrillogenesis of amyloid beta-peptide
    Sandra Rocha, Andreas F. Thünemann, Maria do Carmo Pereira, Manuel A. N. Coelho, Helmuth Möhwald, Gerald Brezesinski · 2008 · Biophysical Chemistry
61. Environmental Enrichment Potently Prevents Microglia-Mediated Neuroinflammation by Human Amyloid  -Protein Oligomers
    Xu, H., Gelyana, E., Rajsombath, M., Yang, T., Li, S., Selkoe, D. · 2016 · Journal of Neuroscience
62. Microglial Receptor for Advanced Glycation End Product-Dependent Signal Pathway Drives β-Amyloid-Induced Synaptic Depression and Long-Term Depression Impairment in Entorhinal Cortex
    Origlia, Nicola, Bonadonna, Camilla, Rosellini, Alfredo, Leznik, Elena, Arancio, Ottavio, Yan, Shirley ShiDu, Domenici, Luciano · 2010 · The Journal of Neuroscience
63. RETRACTED: The amyloid-β oligomer Aβ*56 induces specific alterations in neuronal signaling that lead to tau phosphorylation and aggregation
    Fatou Amar, Mathew A. Sherman, Travis Rush, Megan E. Larson, Gabriel E. Boyle, Chang Liu, Jürgen Götz, Alain Buisson, Sylvain Lesné · 2017 · Science Signaling · Retracted
64. Prevention of Domain Swapping Inhibits Dimerization and Amyloid Fibril Formation of Cystatin C
    Maria Nilsson, Xin Wang, Sylwia Rodziewicz‐Motowidło, Robert Janowski, Veronica Lindström, Patrik Önnerfjord, Gunilla Torstensdotter Westermark, Zbigniew Grzonka, Mariusz Jaskólski, ANDERS O. GRUBB · 2004 · Journal of Biological Chemistry
65. Cofilin-mediated neurodegeneration in alzheimer’s disease and other amyloidopathies
    Michael T. Maloney, James R. Bamburg · 2007 · Molecular Neurobiology
66. Oligomer-specific Aβ toxicity in cell models is mediated by selective uptake
    Sidhartha M. Chafekar, Frank Baas, Wiep Scheper · 2008 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
67. Inhibition of Receptor-mediated Endocytosis Demonstrates Generation of Amyloid β-Protein at the Cell Surface
    Chyung, Jay H., Selkoe, Dennis J. · 2003 · Journal of Biological Chemistry
68. Dietary supplementation with melatonin reduces levels of amyloid beta‐peptides in the murine cerebral cortex
    Debomoy K. Lahiri, De‐Mao Chen, Yuan‐Wen Ge, Stephen Claude Bondy, Edward H. Sharman · 2004 · Journal of Pineal Research
69. Reversal of Fragile X Phenotypes by Manipulation of AβPP/Aβ Levels in Fmr1KO Mice
    Westmark, Cara J., Westmark, Pamela R., O'Riordan, Kenneth J., Ray, Brian C., Hervey, Crystal M., Salamat, M. Shahriar, Abozeid, Sara H., Stein, Kelsey M., Stodola, Levi A., Tranfaglia, Michael et al. · 2011 · PLoS ONE
70. Amino-terminal domain stability mediates apolipoprotein E aggregation into neurotoxic fibrils
    Hatters, Danny M., Zhong, Ning, Rutenber, Earl, Weisgraber, Karl H. · 2006 · Journal of Molecular Biology
71. Atomic force microscopy to study molecular mechanisms of amyloid fibril formation and toxicity in Alzheimer’s disease
    Elizabeth Drolle, Francis T. Hane, Brenda Yasie Lee, Zoya Leonenko · 2014 · Drug Metabolism Reviews
72. Synapse elimination during development and disease: immune molecules take centre stage
    Dorothy P. Schafer, Beth Stevens · 2010 · Biochemical Society Transactions
73. ADDLs and the signaling web that leads to Alzheimer’s disease
    Grant A. Krafft, William L. Klein · 2010 · Neuropharmacology
74. Deregulation of NMDA-receptor function and down-stream signaling in APP[V717I] transgenic mice
    Ilse Dewachter, Robert Kuba Filipkowski, Christina Priller, Laurence Ris, Jacques Neyton, Sophie Croes, Dick Terwel, Maarten Gysemans, Herman Devijver, Peter Borghgraef et al. · 2007 · Neurobiology of Aging
75. Is amyloid-β harmful to the brain? Insights from human imaging studies
    Jagust, William · 2016 · Brain
76. Updated Progress of Nanocarrier-Based Intranasal Drug Delivery Systems for Treatment of Brain Diseases
    Ying Fan, Min Chen, Jinqiang Zhang, Philippe Maincent, Xuefeng Xia, Wen Wu · 2018 · Critical Reviews in Therapeutic Drug Carrier Systems
77. Soluble Aβ oligomers ultrastructurally localize to cell processes and might be related to synaptic dysfunction in Alzheimer's disease brain
    Hideko Kokubo, Rakez Kayed, Charles G. Glabe, Haruyasu Yamaguchi · 2004 · Brain Research
78. Inhibition of the NFAT Pathway Alleviates Amyloid Beta Neurotoxicity in a Mouse Model of Alzheimer's Disease
    Eloïse Hudry, Hai-Yan Wu, Michal Arbel‐Ornath, Tadafumi Hashimoto, Roland Matsouaka, Zhanyun Fan, Tara L. Spires‐Jones, Rebecca A. Betensky, Brian J. Bacskai, Bradley T. Hyman · 2012 · Journal of Neuroscience
79. Docosahexaenoic Acid Protects from Amyloid and Dendritic Pathology in an Alzheimer's Disease Mouse Model
    Greg M. Cole, Sally Ann Frautschy · 2006 · Nutrition and Health
80. Ellagic acid promotes Aβ42 fibrillization and inhibits Aβ42-induced neurotoxicity
    Ying Ning Feng, Shigao Yang, Xueting Du, Xi Zhang, Xiaoxia Sun, Min Zhao, Guiyuan Sun, Rui‐tian Liu · 2009 · Biochemical and Biophysical Research Communications
81. Synaptic targeting by Aβ oligomers (ADDLS) as a basis for memory loss in early Alzheimer's disease
    William L. Klein · 2006 · Alzheimer s & Dementia
82. Bioluminescence imaging of Aβ deposition in bigenic mouse models of Alzheimer's disease
    Watts, Joel C., Giles, Kurt, Grillo, Sunny K., Lemus, Azucena, DeArmond, Stephen J., Prusiner, Stanley B. · 2011 · Proceedings of the National Academy of Sciences
83. The Alzheimer's Amyloid-β(1–42) Peptide Forms Off-Pathway Oligomers and Fibrils That Are Distinguished Structurally by Intermolecular Organization
    William M. Tay, Danting Huang, Terrone L. Rosenberry, Anant K. Paravastu · 2013 · Journal of Molecular Biology
84. Solvent and mutation effects on the nucleation of amyloid β-protein folding
    Luis Cruz, Brigita Urbanc, Jose M. Borreguero, Noel D. Lazo, David B. Teplow, Eugene Stanley · 2005 · Proceedings of the National Academy of Sciences
85. Environmental enrichment ameliorated high-fat diet-induced Aβ deposition and memory deficit in APP transgenic mice
    Masato Maesako, Kengo Uemura, Masakazu Kubota, Akira Kuzuya, Kazuki Sasaki, Megumi Asada, Kiwamu Watanabe, Naoko Hayashida, Masafumi Ihara, Hidefumi Ito et al. · 2011 · Neurobiology of Aging
86. Amyloid-β(1–42) Aggregation Initiates Its Cellular Uptake and Cytotoxicity
    Sha Jin, Niraja Kedia, Eva Illes‐Toth, Ivan Haralampiev, Simon Prisner, Andreas Herrmann, Erich E. Wanker, Jan Bieschke · 2016 · Journal of Biological Chemistry
87. Human tau increases amyloid β plaque size but not amyloid β‐mediated synapse loss in a novel mouse model of Alzheimer's disease
    Rosemary J. Jackson, Nikita Rudinskiy, Abigail G. Herrmann, Shaun Croft, JeeSoo Monica Kim, Veselina Petrova, Juan José Ramos‐Rodríguez, Rose Pitstick, Susanne Wegmann, Mónica Garcı́a-Alloza et al. · 2016 · European Journal of Neuroscience
88. The storm before the quiet: neuronal hyperactivity and aβ in the presymptomatic stages of Alzheimer’s disease
    Stargardt, Anita, Swaab, Dick F., Bossers, Koen · 2015 · Neurobiology of Aging
89. Dendritic vulnerability in neurodegenerative disease: insights from analyses of cortical pyramidal neurons in transgenic mouse models
    Jennifer Irene Luebke, Christina M. Weaver, Anne B. Rocher, Alfredo Rodriguez, Johanna L. Crimins, Dara L. Dickstein, Susan L. Wearne, Patrick R. Hof · 2010 · Brain Structure and Function
90. Redox proteomics and amyloid β-peptide: Insights into Alzheimer disease
    Butterfield, D. Allan, Boyd‐Kimball, Debra · 2019 · Journal of Neurochemistry
91. Synaptic Dysfunction in Alzheimer’s Disease
    Elena E. Marcello, Roberta Epis, Claudia Saraceno, Mónica Di Luca · 2012 · Advances in experimental medicine and biology
92. Delineating the Mechanism of Alzheimer’s Disease Aβ Peptide Neurotoxicity
    Cappai, Roberto, Barnham, Kevin J. · 2008 · Neurochemical Research
93. The transcription factor XBP1s restores hippocampal synaptic plasticity and memory by control of the Kalirin-7 pathway in Alzheimer model
    Moustapha Cissé, Eric Duplan, Thomas Lorivel, Julie Dunys, Charlotte Bauer, Xavier Meckler, Yannis Gerakis, Inger Lauritzen, Frédéric Checler · 2016 · Molecular Psychiatry
94. Vascular Risk and β ‐Amyloid Are Synergistically Associated with Cortical Tau
    Jennifer S. Rabin, Hyun‐Sik Yang, Aaron P. Schultz, Bernard Jimmy Hanseeuw, Trey Hedden, Anand Viswanathan, Jennifer R. Gatchel, Gad A. Marshall, Emily P. Kilpatrick, Hannah Klein et al. · 2018 · Annals of Neurology
95. The effect of insomnia on development of Alzheimer’s disease
    Shaghayegh Sadeghmousavi, Mahsa Eskian, Farzaneh Rahmani, Nima Rezaei · 2020 · Journal of Neuroinflammation
96. In Vitro and Mechanistic Studies of an Antiamyloidogenic Self-Assembled Cyclic d , l -α-Peptide Architecture
    Michal Richman, Sarah Wilk, Marina Chemerovski‐Glikman, Sebastian K.T.S. Wärmländer, Anna Wahlström, Astrid Gräslund, Shai Rahimipour · 2013 · Journal of the American Chemical Society
97. Protein aggregation as a paradigm of aging
    Ariel B. Lindner, Alice Démarez · 2009 · Biochimica et Biophysica Acta (BBA) - General Subjects
98. Different β-amyloid oligomer assemblies in Alzheimer brains correlate with age of disease onset and impaired cholinergic activity
    Fuxiang Bao, Linn Wicklund, Pascale N. Lacor, William L. Klein, Agneta K. Nordberg, Amelia Marutle · 2011 · Neurobiology of Aging
99. CCL2 Accelerates Microglia-Mediated Aβ Oligomer Formation and Progression of Neurocognitive Dysfunction
    Kiyota, Tomomi, Yamamoto, Masaru, Xiong, Huangui, Lambert, Mary P., Klein, William L., Gendelman, Howard E., Ransohoff, Richard M., Ikezu, Tsuneya · 2009 · PLoS ONE
100. Microglial large extracellular vesicles propagate early synaptic dysfunction in Alzheimer’s disease
     Gabrielli, Martina, Prada, Ilaria, Joshi, Pooja, Falcicchia, Chiara, D’Arrigo, Giulia, Rutigliano, Grazia, Battocchio, Elisabetta, Zenatelli, Rossella, Tozzi, Francesca, Radeghieri, Annalisa et al. · 2022 · Brain